P1604: IMPACT OF THROMBOPOIETIN LEVEL ON PLATELET RESPONSE IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA TREATED WITH RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR
David Kuter,
Nichola Cooper,
Umer Khan,
Ahmed Daak,
Waleed Ghanima
Affiliations
David Kuter
1 Massachusetts General Hospital, Harvard Medical School, Hematology Division, Boston, United States
Nichola Cooper
2 Hammersmith Hospital, Department of Medicine, London, United Kingdom
Umer Khan
3 Sanofi, Biostatistics, Bridgewater, United States
